Home › Meningioma › Texas › Houston
Meningioma clinical trials in Houston, TX
4 studies for Meningioma are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
RecruitingPhase 2
- Memorial Hermann Texas Medical Center, Houston
- UT MD Anderson Cancer Center, Houston
- Memorial Hermann Northeast Hospital, Humble · 17 mi away
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
RecruitingPhase 2
- MD Anderson Cancer Center, Houston
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
RecruitingPhase 2
- UT MD Anderson Cancer Center, Houston
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
RecruitingObservational study
- Baylor St. Luke's Medical Center | Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
Meningioma trials in other cities
- New York City, NY8 studies
- Miami, FL7 studies
- Boston, MA6 studies
- Columbus, OH6 studies
- San Francisco, CA5 studies
- San Diego, CA5 studies
- Atlanta, GA5 studies
- Jacksonville, FL5 studies
- Phoenix, AZ4 studies
- Arlington, VA4 studies
- Detroit, MI4 studies
- Durham, NC3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)121 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia85 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer61 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.